Who we work with, and who we turn down

We decline gambling, adult content, pyramid schemes and multi-level marketing, payday and predatory lending, essay mills, counterfeit goods, unlicensed pharmaceuticals, unregistered securities and crypto promotion schemes, and any work whose purpose is to deceive a platform or a reader. We accept regulated and health-adjacent sectors, but only under stricter rules than we apply to anything else, because Google holds those sites to a higher standard and generic marketing actively damages them.

Why we publish this at all

Two reasons, and neither of them is virtue. First, our link building depends on real editors at real publications agreeing to publish. The moment we place gambling or adult content through those relationships, they close, and every other client on our books loses access to them. A publisher network is a shared asset and one bad campaign burns it for everybody.

Second, an agency that will take anything is an agency with no standard, and a client cannot tell the difference between that and an agency with a standard until something goes wrong. This page is how you check before you buy.

Sectors we decline

We will not take this work at any price. If you are in one of these categories, we would rather tell you now than take a deposit and disappoint you:

• Gambling and betting. Casinos, sportsbooks, betting tipsters, affiliate sites for any of the above, and loot-box or skin-gambling products.
• Adult content. Pornography, escort services, and adult subscription platforms.
• Pyramid schemes and multi-level marketing. Including recruitment-led "business opportunity" offers and high-yield investment programmes.
• Predatory lending. Payday loans, doorstep lending, and debt products designed around rollover fees.
• Academic dishonesty. Essay mills, exam proxies, and assignment writing services.
• Counterfeit and grey market goods. Replica products, unauthorised resale of licensed software, and cracked media.
• Unlicensed health products. Prescription medication sold without a prescription, unapproved treatments, and anything marketed as a cure without evidence.
• Unregistered securities and crypto promotion. Token launches marketed as investments without registration, and any campaign whose mechanism depends on new buyers arriving.
• Deception as the product. Fake reviews, bought engagement, impersonation of a real person or organisation, cloaking, and anything that only works if a platform or a reader is misled.

We also decline individual campaigns in otherwise acceptable sectors where the specific brief would require any of the above.

Sectors we accept, with stricter rules

Google classifies pages that can affect somebody's health, financial stability, safety or wellbeing as Your Money or Your Life content, and holds them to a much higher standard of experience, expertise, authoritativeness and trust. That is not a marketing inconvenience, it is the correct policy, and it changes how the work has to be done.

In practice, generic marketing damages a YMYL site. Anonymous articles, thin content, and links from sites with no topical relevance all read as low trust signals precisely where trust is weighted most heavily. We have seen more YMYL sites harmed by cheap SEO than helped by it.

So for health and medical, finance and insurance, legal, tax, safety-critical products, and anything aimed at vulnerable people, we work under these rules:

• Named, credentialed authorship. Content carries a real byline with real credentials, not a house name. Where we cannot source a suitably qualified writer, we say so rather than substituting a generalist.
• Expert review before publication. Medical content is reviewed by a clinician, financial content by someone qualified in that jurisdiction. The reviewer is named on the page with the review date.
• Primary sources, cited. Claims link to research, regulator guidance or official statistics, not to another blog repeating the same claim.
• Topical relevance over domain authority. A DA 70 link from an unrelated site is worth less to a YMYL page than a DA 30 link from a recognised sector publication, and can be actively harmful. We will recommend the lower number.
• Regulatory review first. Where your sector has advertising rules, financial promotion rules or medical claims rules, we check the campaign against them before it runs, and we will not run copy that breaches them even if you approve it.
• No outcome claims. We will not write, and will not let a campaign imply, guaranteed medical or financial results.

This work costs more and moves more slowly, and we quote it that way. If that is not what you are looking for, we are not the right agency, and we would rather establish that on this page than three invoices in.

How this affects our own site

We publish pricing, benchmarks and business advice, so the same standard applies to us. That is why every price on this site is the price the checkout charges, why our market comparisons name their sources, why we state plainly what we do not guarantee, and why our terms list the outcomes nobody can promise. An agency asking you to trust it on trust signals should be legible on its own.

If we decline

We will tell you directly and, where we can, point you to somebody better suited. Declining is not a negotiating position and there is no price at which the list above changes. If you have already paid, you are refunded in full under our refunds policy.

Reporting a breach

If you believe work carried out in our name breaches this policy, tell us at support@beta-backlink.com and we will investigate. We would rather hear it from you than from a publisher withdrawing a relationship.